[Occupational asthma: an experimental asthma. Apropos of isocyanate-induced asthma]. 1993

G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
Service de Pneumologie, Hôpital Civil, Hôpitaux Universitaires de Strasbourg.

Isocyanate-induced occupational asthma is a model of experimental asthma related to the environment. Many of its features are identical with those of allergic asthma by sensitization to air-borne allergens. Exposure to isocyanate before the first symptoms of asthma varies from a few weeks to several years. The prevalence of isocyanate-induced asthma has been estimated at 5 to 25%. Atopy is found in less than 30% of the cases. A significant increase of HRBNS can be demonstrated in most patients, but it may be absent. It may also fluctuate with the working periods or after a bronchial provocation test with isocyanate. Elimination of this compound reduces the HRBNS level in only one quarter of the cases. Delayed or biphasic reactions are frequent: 30 to 60% depending of the authors. An early diagnosis followed by total elimination may result in complete cure, but more than 50% of the patients remain symptomatic and with HRBNS. An IgE-dependent mechanism can be demonstrated in about 20% of the cases. The course of isocyanate-induced asthma is interesting in that the same phenomena are probably observed in chronic asthma resulting from repeated exposures to environmental allergens.

UI MeSH Term Description Entries
D009784 Occupational Diseases Diseases caused by factors involved in one's employment. Diseases, Occupational,Occupational Illnesses,Disease, Occupational,Illnesse, Occupational,Illnesses, Occupational,Occupational Disease,Occupational Illnesse
D001985 Bronchial Provocation Tests Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma. Allergen Bronchial Provocation Tests,Allergen Challenge, Endobronchial,Antigen Bronchial Provocation Tests,Bronchial Allergen Challenge,Bronchial Challenge Tests,Inhalation Provocation Tests,Provocation Tests, Bronchial,Endobronchial Challenge Tests,Allergen Challenge, Bronchial,Allergen Challenges, Bronchial,Allergen Challenges, Endobronchial,Bronchial Allergen Challenges,Bronchial Challenge Test,Bronchial Provocation Test,Challenge Test, Bronchial,Challenge Test, Endobronchial,Challenge Tests, Bronchial,Challenge Tests, Endobronchial,Challenge, Bronchial Allergen,Challenge, Endobronchial Allergen,Challenges, Bronchial Allergen,Challenges, Endobronchial Allergen,Endobronchial Allergen Challenge,Endobronchial Allergen Challenges,Endobronchial Challenge Test,Inhalation Provocation Test,Provocation Test, Bronchial,Provocation Test, Inhalation,Provocation Tests, Inhalation,Test, Bronchial Challenge,Test, Bronchial Provocation,Test, Endobronchial Challenge,Test, Inhalation Provocation,Tests, Bronchial Challenge,Tests, Bronchial Provocation,Tests, Endobronchial Challenge,Tests, Inhalation Provocation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016535 Bronchial Hyperreactivity Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory. Bronchial Hyperreactivities,Hyperreactivities, Bronchial,Hyperreactivity, Bronchial
D017953 Isocyanates Organic compounds that contain the -NCO radical. Isocyanate

Related Publications

G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
August 1984, Orvosi hetilap,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
August 1996, Journal of Korean medical science,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
September 2011, International journal of environmental research and public health,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
January 1982, European journal of respiratory diseases. Supplement,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
March 2022, Ugeskrift for laeger,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
October 1997, Occupational and environmental medicine,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
January 2013, Journal of occupational and environmental hygiene,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
May 2012, Experimental & molecular medicine,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
February 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
G Pauli, and M C Kopferschmitt, and A Dietemann, and M Blaumeiser, and J C Bessot
January 1982, European journal of respiratory diseases. Supplement,
Copied contents to your clipboard!